Terms of Service

1. Acceptance of these Terms

By accessing or using the Services, you agree to these Terms. If you use the Services for an organization, you represent that you are authorized to act for that organization and “you” includes that organization. If you do not agree, do not use the Services.

These Terms incorporate the Privacy Policy, Medical & Regulatory Disclaimer and Responsible AI Use statement where relevant to your use.

2. Contract hierarchy

If your organization has a signed order form, master subscription agreement, pilot agreement, DPA, business associate agreement, statement of work or other written agreement with Bayes Pharma, that agreement controls to the extent it conflicts with these public Terms. Procurement, security and privacy requirements agreed in writing are not replaced by a website update.

3. The Services

Bayes Pharma provides professional software for pharmaceutical and life-sciences workflows, including BayesARC, BayesGenRx, BayesCare, BioAtlas and related tools. Capabilities may include evidence management, scientific computation, model-assisted analysis, MIDD, quality workflows, regulatory context, collaboration and AI-assisted drafting or reasoning.

4. Eligibility, organizations and accounts

• You must be legally capable of entering a binding agreement and, for public self-service use, at least 18 years old.
• You must provide accurate account information and protect credentials, tokens and devices.
• Customer administrators are responsible for assigning users, roles and permissions in line with their organization’s governance.
• You must promptly notify us of suspected account compromise or unauthorized access.

5. Trials, pilots, fees and renewals

Commercial terms, fees, taxes, usage limits, renewal periods and cancellation rights are stated in the applicable order form or checkout flow. A free trial or pilot may be limited in duration, functionality, capacity or support and may be suspended at the end of the stated period. Unless a written agreement says otherwise, fees are non-refundable to the extent permitted by law.

6. Acceptable use

You may use the Services only for lawful, authorized professional purposes. You must not:

• circumvent authentication, authorization, tenancy, rate limits or security controls;
• access another customer’s data or test isolation controls without written authorization;
• upload malware, unlawful content or data you do not have the right to process;
• misrepresent an AI-generated or software-generated output as validated expert judgment;
• use the Services to make an autonomous clinical, quality, safety or regulatory decision where human review is required;
• reverse engineer or copy proprietary components except to the limited extent a mandatory law permits;
• use the Services to develop a competing product through systematic extraction of non-public software, data models or proprietary content; or
• violate export controls, sanctions, privacy, clinical, quality, research or other applicable law.

7. Customer Content

As between you and Bayes Pharma, you retain ownership of Customer Content. You grant Bayes Pharma the limited rights necessary to host, process, transmit, back up and otherwise handle Customer Content to provide, secure and support the Services in accordance with your agreement.

You are responsible for ensuring that you have the rights, permissions and lawful basis needed to provide Customer Content and for the scientific and regulatory meaning of that content. Bayes Pharma does not become the sponsor, manufacturer, investigator, laboratory, healthcare provider or regulatory owner merely because the Service processes your data.

8. AI-assisted features

Some features may use machine learning, language models or other probabilistic methods. Outputs can be incomplete, incorrect, non-reproducible or inappropriate for the intended use. You must evaluate source quality, applicability, uncertainty and consequences before relying on an output.

• Do not treat an AI output as a verified fact solely because it is confidently written.
• Verify calculations, citations, model versions, assumptions and provenance where material.
• Keep qualified human review and segregation-of-duties controls where required by your process.
• Do not use AI-assisted features to bypass local procedures, validation or regulatory accountability.

See Responsible AI Use.

9. Regulated and high-impact use

Bayes Pharma may provide features designed to support regulated workflows, but software availability does not itself establish compliance with FDA, EMA, MHRA, CDSCO, ICH, GxP, 21 CFR Part 11, EU Annex 11, HIPAA or any other framework. Your organization remains responsible for intended-use definition, validation, qualification, SOPs, access governance, audit review, records retention, electronic-signature controls and final decisions applicable to your use.

10. Privacy and data processing

Our handling of website and account data is described in the Privacy Policy. For Customer Content processed on behalf of an organization, the applicable DPA or customer agreement controls. Regional notices cover the United States, Europe and India.

11. Intellectual property

Bayes Pharma and its licensors own the Services, software, interface designs, documentation, trademarks and other proprietary materials, excluding Customer Content and third-party materials. Subject to payment and the applicable agreement, we grant you a limited, non-exclusive, non-transferable right to use the Services during the authorized term.

If you provide feedback, you permit Bayes Pharma to use it without restriction or payment, provided we do not publicly identify you as the source without permission.

12. Confidentiality

Each party must protect the other party’s non-public confidential information using reasonable care and use it only for the agreed purpose. Confidentiality obligations do not apply to information that is public through no breach, already lawfully known, independently developed or lawfully obtained without a duty of confidentiality. Required legal disclosure is permitted subject to applicable notice requirements.

13. Third-party services and data

The Services may link to or interoperate with third-party APIs, scientific databases, cloud platforms, open-source software or other services. Their terms, availability, licenses and data quality may differ from ours. Unless expressly stated in a signed agreement, Bayes Pharma does not warrant third-party services or external scientific data.

14. Availability, maintenance and product changes

We may maintain, update, improve or replace features. We may also limit functionality for security, legal, operational or product-integrity reasons. Enterprise availability commitments, support response times and change-control obligations are governed by the applicable written agreement or SLA, if any.

15. Warranties and disclaimers

Except for warranties expressly stated in a signed agreement, the Services are provided “as is” and “as available” to the fullest extent permitted by law. Bayes Pharma disclaims implied warranties of merchantability, fitness for a particular purpose, non-infringement and any warranty that an output will be scientifically correct, regulatorily acceptable or suitable for a particular decision without independent review.

Nothing in these Terms excludes a warranty or right that cannot legally be excluded.

16. Limitation of liability

To the fullest extent permitted by law, neither party is liable under these Terms for indirect, incidental, special, exemplary, punitive or consequential damages, or for lost profits, revenue, business opportunities or goodwill, arising from use of the Services.

Unless a signed agreement states a different cap, Bayes Pharma’s aggregate liability arising out of the Services will not exceed the fees paid or payable by you for the affected Services during the 12 months before the event giving rise to the claim. This cap does not apply where liability cannot lawfully be limited and does not alter any separate liability allocation in a signed enterprise agreement.

17. Indemnity

To the extent permitted by law, you will defend and indemnify Bayes Pharma against third-party claims arising from your unlawful Customer Content, your material breach of these Terms, or your use of the Services in violation of applicable law or another person’s rights. Any broader or reciprocal indemnity terms for enterprise customers are governed by the signed agreement.

18. Suspension and termination

You may stop using public Services at any time. Paid subscriptions terminate under the applicable order form. We may suspend or terminate access for material breach, non-payment, security risk, unlawful use or where continued service would expose Bayes Pharma, customers or users to material harm. Where commercially reasonable and legally permitted, we will provide notice and an opportunity to cure before termination.

Provisions intended by their nature to survive termination—including confidentiality, payment obligations, IP, disclaimers, liability limits and dispute terms—remain in effect.

19. Export controls, sanctions and restricted parties

You must comply with applicable trade-control, sanctions and export laws in the United States, European jurisdictions, India and any other relevant country. You may not use, export, re-export or make the Services available where prohibited by law or to a person or entity subject to applicable restrictions.

20. Governing law and disputes

If a signed customer agreement specifies governing law or forum, that agreement controls. Otherwise, these Terms are governed by the laws of India, without regard to conflict-of-law rules, and disputes will be subject to the courts with competent jurisdiction in Hyderabad, Telangana, India.

Mandatory consumer, employment, privacy or other statutory rights that cannot lawfully be waived remain unaffected. Before filing formal proceedings, the parties should make a good-faith effort to resolve a business dispute through escalation to authorized representatives.

21. Changes to these Terms

We may update these Terms for changes to law, Services or business operations. Material changes will be identified by an updated date and, where required, additional notice. Changes do not retroactively modify a signed enterprise agreement.

22. Contact

Questions about these Terms, contracting or enterprise use can be sent to info@bayespharma.com.